Our current results revealed a role of tumor-intrinsic innate immune response, specifically the protein effectors of the STING-IFN-I signaling stimulated by hDT806 in tumor control in HNSCC. This evidence concerns the gene STING1 and head and neck squamous cell carcinoma.